(Q44115673)

29 November 2017

title

Characteristics and outcomes of acute myelogenous leukemia patients with very late relapse (>5 years). (English)

1 reference

29 November 2017

1 reference

Suzanne Kamel-Reid

12

0 references

Aaron Schimmer

object named as

Aaron D Schimmer

4

0 references

author name string

Bruno C Medeiros

1

1 reference

29 November 2017

Mark D Minden

2

1 reference

29 November 2017

Andre C Schuh

3

1 reference

29 November 2017

Karen Yee

5

1 reference

29 November 2017

Jeff H Lipton

6

1 reference

29 November 2017

Hans A Messner

7

1 reference

29 November 2017

Vikas Gupta

8

1 reference

29 November 2017

Kathy Chun

9

1 reference

29 November 2017

Wei Xu

10

1 reference

29 November 2017

Prabodh Das

11

1 reference

29 November 2017

Joseph M Brandwein

13

1 reference

29 November 2017

language of work or name

1 reference

1 January 2007

1 reference

29 November 2017

1 reference

29 November 2017

volume

48

1 reference

29 November 2017

issue

1

1 reference

29 November 2017

page(s)

65-71

1 reference

29 November 2017

cites work

Acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1080%2F10428190601043252

Farnesyltransferase inhibitors: novel compounds in development for the treatment of myeloid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601043252

The treatment of acute myeloid leukemia in first relapse: a comprehensive review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601043252

Biology and management of relapsed acute myeloid leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601043252

Outcome of patients with acute myelogenous leukemia after second salvage therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601043252

Late relapses evolve from slow-responding subclones in t(12;21)-positive acute lymphoblastic leukemia: evidence for the persistence of a preleukemic clone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601043252

Interruption of tumor dormancy by a transient angiogenic burst within the tumor microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601043252

Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601043252

Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601043252

Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601043252

Extramedullary relapse after allogeneic bone marrow transplantation for haematological malignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601043252

Extramedullary tumors of myeloid blasts in adults as a pattern of relapse following allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190601043252

10.1080/10428190601043252

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference